Megaphone Eyewire headlines are now available as a weekly podcast! Listen Now

Now Playing

Eyewire TV September 27th 2023 thumbnail

Introduction

FDA Approves Ryzumvi for Reversal of Pharmacologically-Induced Mydriasis thumbnail

FDA Approves Ryzumvi for Reversal of Pharmacologically-Induced Mydriasis

Théa Pharma Launches Iyuzeh in US as Preservative-Free Glaucoma Treatment thumbnail

Théa Pharma Launches Iyuzeh in US as Preservative-Free Glaucoma Treatment

CMS Assigns Permanent J-Code to Apellis’ GA treatment Syfovre thumbnail

CMS Assigns Permanent J-Code to Apellis’ GA Treatment Syfovre


Previous EyewireTV Episodes